Reichenbacher; Katharina

Patent Applications and Registrations

Patent applications and USPTO patent grants for Reichenbacher; Katharina.The latest application filed is for "forms of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5- -hydroxymethyl oxazolidin-2-one dihydrogen phosphate".

Company Profile

1.14.15

Reichenbacher; Katharina - Riehen CH
Reichenbacher; Katharina - Rheinfelden DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5- -hydroxymethyl oxazolidin-2-one dihydrogen phosphate Grant 10,442,829 - Reichenbacher , et al. Oc	2019-10-15
Forms Of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5- -hydroxymethyl Oxazolidin-2-one Dihydrogen Phosphate App 20180251482 - Reichenbacher; Katharina ; et al.	2018-09-06
Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5- -hydroxymethyl oxazolidin-2-one dihydrogen phosphate Grant 10,065,947 - Reichenbacher , et al. September 4, 2	2018-09-04
Forms Of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5- -hydroxymethyl Oxazolidin-2-one Dihydrogen Phosphate App 20180244704 - Reichenbacher; Katharina ; et al.	2018-08-30
Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5- -hydroxymethyl oxazolidin-2-one dihydrogen phosphate Grant 9,988,406 - Reichenbacher , et al. June 5, 2	2018-06-05
Forms Of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5- -hydroxymethyl Oxazolidin-2-one Dihydrogen Phosphate App 20170275315 - Reichenbacher; Katharina ; et al.	2017-09-28
Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5- -hydroxymethyl oxazolidin-2-one dihydrogen phosphate Grant 9,624,250 - Reichenbacher , et al. April 18, 2	2017-04-18
Crystalline sodium salt of an HIV integrase inhibitor Grant 9,458,146 - Blatter , et al. October 4, 2	2016-10-04
Forms Of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5- -hydroxymethyl Oxazolidin-2-one Dihydrogen Phosphate App 20160176905 - Reichenbacher; Katharina ; et al.	2016-06-23
Crystalline asenapine hydrochloride salt forms Grant 9,303,036 - Blatter , et al. April 5, 2	2016-04-05
Crystalline salts of Asenapine with organic di-acids and tri-acids Grant 9,169,262 - Blatter , et al. October 27, 2	2015-10-27
Crystalline compound of 7-[(3R)-3-amino-1-oxo-4-(2, 4, 5-trifluorophenyl)butyl]-5, 6, 7, 8-tetrahydro-3-(tri fluoromethyl)-1, 2, 4 -triazolo[4,3-A]pyrazin Grant 8,916,559 - Blatter , et al. December 23, 2	2014-12-23
Novel Crystalline Salts Of Asenapine App 20140163083 - Blatter; Fritz ; et al.	2014-06-12
Crystalline Sodium Salt Of An Hiv Integrase Inhibitor App 20140135353 - Blatter; Fritz ; et al.	2014-05-15
Novel Crystalline Salts Of Asenapine With Organic Di-acids And Tri-acids App 20140128444 - Blatter; Fritz ; et al.	2014-05-08
Novel Crystalline Asenapine Hydrochloride Salt Forms App 20140121259 - Blatter; Fritz ; et al.	2014-05-01
Crystalline Form Of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin- 5-yl)-3-fluorophenyl)-5-hydroxymethyl Oxazolidin-2-one Dihydrogen Phosphate App 20130310343 - Reichenbacher; Katharina ; et al.	2013-11-21
Crystalline form of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxy- methyl oxazolidin-2-one dihydrogen phosphate Grant 8,426,389 - Reichenbacher , et al. April 23, 2	2013-04-23
Crystalline Compound Of 7-[(3r)-3-amino-1-oxo-4-(2, 4, 5-trifluorphenyl)butyl]-5, 6, 7, 8-tetrahydro-3-(tri Fluormethyl)-1, 2, 4 -triazolo[4,3-a]pyrazin App 20120142693 - Blatter; Fritz ; et al.	2012-06-07
Crystalline Form Of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin- 5-yl)-3-fluorophenyl)-5-hydroxymethyl Oxazolidin-2-one Dihydrogen Phosphate App 20100227839 - Reichenbacher; Katharina ; et al.	2010-09-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.